Alector (ALEC) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Alector's Strategic Advances in Immuno-Neurology
TipRanksNov 21 22:56 ET
Alector Secures Funding to Advance Clinical Trials
TipRanksNov 14 16:36 ET
Express News | Alector Inc - Expects Current Cash to Fund Operations Through 2026
ReutersNov 14 16:06 ET
Alector Secures Flexible Credit Facility for Up to $50 Million From Hercules Capital
GlobeNewswireNov 14 16:05 ET
Express News | Alector Secures Flexible Credit Facility for up to $50 Million From Hercules Capital
ReutersNov 14 16:05 ET
Press Release: Alector Secures Flexible Credit Facility for Up to $50 Million From Hercules Capital
Dow JonesNov 14 16:05 ET

Comments

Jaguar8

Sep 19 07:24

NEWS

$Alector (ALEC.US)$
Alector Presents Baseline Characteristics for Pivotal INFRONT-3 Phase 3 Clinical Trial at the 14th International Conference on Frontotemporal Dementias (ISFTD 2024)
Alector (Nasdaq: ALEC) presented baseline characteristics for its pivotal INFRONT-3 Phase 3 clinical trial at the 14th International Conference on Frontotemporal Dementias. The trial evaluates latozinemab, a novel monoclonal antibody, for treating frontotemporal dementia with progranulin gene mutation (FTD-GR...

1

Jaguar8

Jul 28 07:06

NEWS

$Alector (ALEC.US)$
Alector Presents Baseline Characteristics for INVOKE-2 Phase 2 Clinical Trial of AL002 at the Alzheimer's Association International Conference® 2024 (AAIC®)
Alector presented baseline characteristics for the INVOKE-2 Phase 2 clinical trial of AL002, a TREM2 agonist, at AAIC® 2024.
The trial, involving 381 participants with early Alzheimer's disease (AD), is the first global Phase 2 study evaluating a TREM2 agonist's safety and efficacy in slowing AD progression.
Key point...

1

Moomoo AI

Jan 19 13:58

Alector's low P/S ratio may be due to poor revenue performance and expectations of this trend continuing. Future revenue growth is expected to be significantly lower than the industry, possibly causing discomfort among shareholders and a drop in share price.

Little Excitement Around Alector, Inc.'s (NASDAQ:ALEC) Revenues As Shares Take 27% Pounding

Moomoo AI

Dec 12, 2023 06:41

Arnon Rosenthal's major sale indicates insiders may expect a lower price. Despite high insider ownership, the absence of insider purchases and significant sales stirs uncertainty about the company's prospects and arouses investor caution.

Alector Insiders Sell US$711k Of Stock, Possibly Signalling Caution

Moomoo AI

Oct 20, 2023 05:26

Despite declining revenue, Alector's cash runway looks promising. However, significant cash burn could necessitate capital raise, potentially diluting shareholder value. Risk factors warrant careful scrutiny before investment.

Is Alector (NASDAQ:ALEC) In A Good Position To Deliver On Growth Plans?

ALEC Alector

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target